| Stage |
Phase |
Principal Investigator |
Study prefix |
Study number |
Title (click hyperlink for more information) |
| IIIB or IV | II | Alex Adjei, MD PhD | NCG | 124807 | Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer |
| I | Saikrishna Yendamuri, MD | NCG | 158409 | (CALGB 150901) MicroRNA Profiling Using an Updated Microarray to Prognosticate Early Lung Cancer |
| IV | I | Todd Demmy, MD | I | 70005 | A Phase I Study of Targeted Lung Chemotherapy in the Treatment of Unresectable or Advanced Stage Lung Cancer and Metastatic Sarcoma |
| II | Alex Adjei, MD PhD | I | 130508 | Randomized Phase II Study with a Safety Lead-In of the Anti-IGF-1R Monoclonal Antibody IMC-A12 in Combination with Erlotinib Compared with Erlotinib Alone in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Who have Failed at least One Platinum-Containing Chemotherapy Regimen |
| II | Todd Demmy, MD | I | 98707 | A Phase II Study of Photodynamic Therapy (PDT) Using 2-[Hexyloxyethyl]-2 Devinyl Pyropheophorbide-A (HPPH) for Treatment of Advanced Obstructing Endobronchial Lung Cancer |
| III | II | Jorge Gomez, MD | I | 65605 | Concurrent Carboplatin, Paclitaxel and Selenomethionine in Combination with Radiation for Patients with Unresectable Stage III Non-Small Cell Lung Cancer: A Phase II Trial, Multi-Center Trial |
| IIIA, IIIB | II | Grace Dy, MD | I | 31104 | Molecular and Genetic Changes in Patients with Resectable Non-Small Lung Cancer (NSCLC) Following Neoadjuvant Chemotherapy with Cisplatin and Alimta- A Phase II Study |
| N/A | N/A | Mary Reid, PhD | I | 62305 | Lung Bronchoscopy Research Samples & Database |
| N/A | N/A | Todd Demmy, MD | NCG / CALGB | 37304 | (CALGB 140202) The CALGB Lung Cancer Tissue Bank |
| III | Chukwumere Nwogu, MD | NCG / CALGB | 111407 | (CALGB 140503) A Phase III Randomized Trial of Lobectomy Versus Sublobar Resection for Small (< 2 cm) Peripheral Non-Small Cell Lung Cancer |
| Pilot | Alex Adjei, MD PhD | I | 90206 | Pilot Study of Oral Calcitriol in Patients at High Risk for Lung Cancer |
| I | Alex Adjei, MD PhD | I | 155209 | (GDC4628g) A Phase 1b, Open-Label, Dose-Escalation Study of the Safety and Pharmacology of P13-Kinase Inhibitor GDC-0941 in Combination with Paclitaxel and Carboplatin With or Without Bevacizumab in Patients with Advanced Non-Small Lung Cancer |
| I | Brahm Segal, MD | I | 76006 | Longitudinal Evaluation of Serum Levels of ST6Gal-1 and Serum Sialylation |
| II | Anurag Singh, MD | I | 124407 | A Phase II Randomized Study of Stereotactic Body Radiation Therapy (SBRT) Regimes for Medically Inoperable Patients with Node Negative, Peripheral Non- Small Cell Lung Cancer |
| I | Chukwumere Nwogu, MD | I | 97306 | Radioguided Detection of Lymph Node Metastasis in Non-Small Cell Lung Cancer |
| I/II | Anurag Singh, MD | NCG | 153009 | (RTOG 0813) Seamless Phase I/II Study of Stereotatic Lung Radiotherapy (SBRT) for Early Stage, Centrally Located Non-Small Cell Lung Cancer (NSCLC) Medically Inoperable Patients |